Insider Transactions in Q2 2023 at Atara Biotherapeutics, Inc. (ATRA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2023
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
14,291
-1.98%
|
$14,291
$1.66 P/Share
|
|
May 31
2023
|
Beth C Seidenberg |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+33.01%
|
-
|
|
May 31
2023
|
William K Heiden |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+34.34%
|
-
|
|
May 31
2023
|
Eric Dobmeier |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+32.85%
|
-
|
|
May 31
2023
|
Ameet Mallik |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+42.38%
|
-
|
|
May 31
2023
|
Matthew K Fust |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+34.34%
|
-
|
|
May 31
2023
|
Carol Giltner Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+23.13%
|
-
|
|
May 31
2023
|
Maria Grazia Roncarolo |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+39.18%
|
-
|
|
May 16
2023
|
Eric J Hyllengren EVP, CFO |
SELL
Open market or private sale
|
Direct |
7,918
-1.7%
|
$15,836
$2.04 P/Share
|
|
May 16
2023
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
29,766
-3.97%
|
$59,532
$2.04 P/Share
|
|
May 16
2023
|
Charlene A. Banard EVP, Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
19,040
-6.45%
|
$38,080
$2.04 P/Share
|
|
May 16
2023
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,389
-1.51%
|
$16,778
$2.04 P/Share
|